Results 201 to 210 of about 95,261 (258)

Frizzled‐9 Expression Is Associated With Aggressive Clinicopathological Features and Reduced Overall Survival in Invasive Breast Carcinoma

open access: yesPathology International, Volume 76, Issue 3, March 2026.
Graphical summary illustrating the evaluation of FZD9 in breast cancer. FZD9 protein expression was assessed by immunohistochemistry in 81 breast tumor samples and further investigated in breast cancer cell lines exposed to cytotoxic and epigenetic treatments. Higher FZD9 expression was associated with aggressive clinicopathological features and poorer
Daniel Rodrigues de Bastos   +3 more
wiley   +1 more source

Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist After Chemotherapy Depend on BCL-XL for Survival. [PDF]

open access: yesCells
Andrzejewski S   +14 more
europepmc   +1 more source

Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models. [PDF]

open access: yesCancer Res Commun
Brim BC   +19 more
europepmc   +1 more source

BCL-XL Protects ASS1-Deficient Cancers from Arginine Starvation-Induced Apoptosis. [PDF]

open access: yesClin Cancer Res
Panda PK   +13 more
europepmc   +1 more source

GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells. [PDF]

open access: yesOncogenesis
Zhang L   +12 more
europepmc   +1 more source

Bax- Bcl-xL interaction dynamics during the progression of cell cycle and cell death using FLIM-FRET. [PDF]

open access: yesCell Stress
Halikar AM   +7 more
europepmc   +1 more source

Discovery of Dual BCL-xL/BCL-w Degraders by Exploiting the Bis(sulfonyl)benzene Ring of ABT-263 as a Linkage Vector. [PDF]

open access: yesJ Med Chem
Poddar SK   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy